"We are disappointed not to be able to recommend everolimus as a second-line treatment option for patients with advanced renal cell carcinoma," he said. ...
4, 2010) — The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, ...
Discountvouchers.co.uk - Paul Russell - 4 hours ago
It is suitable for patients who have failed on vascular endothelial growth factor-targeted therapy, a first line treatment for advanced renal cell carcinoma...
Final results from a randomized Phase 3 trial of Sutent, which is approved to treat renal cell carcinoma, a type of kidney cancer, and as a backup treatment ...
Tumor necrosis is a potential marker of recurrence and survival after surgery for renal cell carcinoma. We determined whether a correlation exists between ...
Philadelphia Inquirer - Mike Jensen - Feb 2, 2010
"Scary is getting diagnosed with cancer," Koons said. That summer, the Villanova student learned she had clear cell renal carcinoma, a form of kidney cancer...
... 48 percent more likely to develop a clear-cell renal cell cancer (RCC) than those with a body-mass index(BMI) of less than 30, the cutoff for obesity. ...